[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355630-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355630-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pervasive-enhanced-transcription-in-inflammatory-breast-cancer-tumors-and-pbmcs-impacts-rna-splicing-and-intronic-rnas-in-plasma","Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma","","Inflammatory breast cancer (IBC) is an aggressive subtype lacking clear genomic differences or robust biomarkers compared with non-IBC. TGIRT-seq uncovers extensive RNA differences across tumors, PBMCs, and plasma, distinguishing IBC patients from non-IBC patients and healthy donors. By mapping reads to reference genome/transcriptome sequences and quantifying intron-to-exon read depth ratios, the study links elevated intron retention to rate-limiting splicing and reduced mRNA production. Plasma RNA profiles reflect intronic fragments in IBC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pervasive-enhanced-transcription-in-inflammatory-breast-cancer-tumors-and-pbmcs-impacts-rna-splicing-and-intronic-rnas-in-plasma/355630/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pervasive-enhanced-transcription-in-inflammatory-breast-cancer-tumors-and-pbmcs-impacts-rna-splicing-and-intronic-rnas-in-plasma/355630.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What technique was used to reveal RNA differences in inflammatory breast cancer?","Question",{"text":63,"@type":64},"TGIRT-seq was used to compare tumors, PBMCs, and plasma RNAs and to distinguish IBC patients from non-IBC patients and healthy donors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study analyze RNA transcription and posttranscriptional regulation?",{"text":68,"@type":64},"It mapped reads to genome and transcriptome reference sequences and quantified intron-to-exon read depth ratios (IDRs) to assess transcriptional and posttranscriptional gene regulation.",{"name":70,"@type":61,"acceptedAnswer":71},"What RNA pattern in plasma is associated with IBC versus non-IBC?",{"text":72,"@type":64},"In IBC patient plasma, overrepresented protein-coding gene RNAs are largely intron RNA fragments, whereas non-IBC patients and healthy donors show largely mRNA fragments.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355630,1790193134,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","CANCER  \nPervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma  \nDennis Wylie1†, Xiaoping Wang2,3†‡, Jun Yao1†, Hengyi Xu1†, Elizabeth A. Ferrick-Kiddie1, Toshiaki Iwase2,3‡, Savitri Krishnamurthy3,4*, Naoto T. Ueno2,3*‡, Alan M. Lambowitz1*  \nInflammatory breast cancer (IBC), an aggressive and lethal breast cancer subtype, lacks unequivocal genomic differences or robust biomarkers that differentiate it from non-IBC. Here, TGIRT-seq revealed myriad differences in tumors, PBMC, and plasma RNAs that distinguished IBC patients from non-IBC patients and healthy donors across different tested breast cancer subtypes. By mapping reads to genome and transcriptome reference sequences and quantitating intron-to-exon read depth ratios (IDRs), we developed methods for parallel analysis of transcriptional and posttranscriptional gene regulation. This analysis identified numerous protein-coding genes in IBC patient tumors and PBMCs with high IDRs, suggesting rate-limiting RNA splicing that decreases mRNA production. Mirroring gene expression differences in tumors and PBMCs, overrepresented protein-coding gene RNAs in IBC patient plasma were largely intron RNA fragments, while those in non-IBC patient and healthy donor plasma were largely mRNA fragments. Our findings provide insights into IBC and should enable monitoring disease progression by liquid biopsy.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nHigh-throughput RNA sequencing (RNA-seq) is widely used to identify RNA biomarkers for diseases and environmental stimuli ( 1) . Commonly, an initial comprehensive RNA-seq of one or more RNA biotypes is performed to identify candidate biomarkers, which are then validated by targeted assays in larger numbers of samples. Most desired are biomarkers that can be detected by minimally invasive blood-based assays and reflect molecular aberrations and immune responses throughout the body. For this purpose, labile blood-based RNA biomarkers are potentially advantageous by enabling diagnosis and real-time monitoring of disease progression and response to treatment. Thus far, most cellular and blood-based RNA biomarker studies have focused on polyadenylated mRNAs or mature microRNAs (miRNAs) . However, these approaches miss numerous long noncoding RNAs (lncRNAs) and small noncoding RNAs (sncRNAs), as well as intron and Repeat-element RNAs that can be detected in blood  \nbut have not been widely explored for biomarker potentials (2, 3).  \nInflammatory breast cancer (IBC) is the most lethal and aggressive breast cancer subtype (4). It comprises only 2 to 4% of breast cancer cases in the United States but causes 8 to 10% of breast cancer deaths (5). Because of its high recurrence rate and propensity to metastasize, patients with IBC have a shorter median overall survival time (5 years) than those with other types of breast cancer (denoted as non-IBC) (6– 9). Patients with triple-negative IBC (TN-IBC)—negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal  \n1departments of Molecular Biosciences and Medicine / Oncology, University of texas at Austin, Austin, tX 78712, USA. 2department of Breast Medical Oncology, the University of texas Md Anderson cancer center, houston, tX 77030, USA. 3Morgan Welch inflammatory Breast cancer Research Program and clinic, the University of texas Md Anderson cancer center, houston, tX 77030, USA. 4department of Anatomical Pathology, the University of texas Md Anderson cancer center, houston, tX 77030, USA.  \n*[corresponding author. email:](corresponding author. email:) [skrishna@mdanderson.org](skrishna@mdanderson.org) (S.K.); nueno@cc.hawaii. edu (n.t. U.); lambowitz@austin. utexas.edu (A. M. l.","cbCaiqv39NcNzVWz","https://ap.wps.com/l/cbCaiqv39NcNzVWz","pdf",8579461,23,"English","# Introduction\n## RNA biomarkers and minimally invasive blood-based assays\n## Gaps in current RNA-seq biomarker approaches\n## Why inflammatory breast cancer needs new biomarkers\n## Limitations of retroviral reverse transcriptases\n## Advances with TGIRTs and non-LTR retroelement RTs","[{\"question\":\"What technique was used to reveal RNA differences in inflammatory breast cancer?\",\"answer\":\"TGIRT-seq was used to compare tumors, PBMCs, and plasma RNAs and to distinguish IBC patients from non-IBC patients and healthy donors.\"},{\"question\":\"How did the study analyze RNA transcription and posttranscriptional regulation?\",\"answer\":\"It mapped reads to genome and transcriptome reference sequences and quantified intron-to-exon read depth ratios (IDRs) to assess transcriptional and posttranscriptional gene regulation.\"},{\"question\":\"What RNA pattern in plasma is associated with IBC versus non-IBC?\",\"answer\":\"In IBC patient plasma, overrepresented protein-coding gene RNAs are largely intron RNA fragments, whereas non-IBC patients and healthy donors show largely mRNA fragments.\"}]","Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma | PDF",1790120215,58,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8aa62b73b6ce4810df234fb475c1e49b.webp",983,1250,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f45e46df6688994b23ce264a988b3bd.webp",982,1249,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6fd447b585574509d0f6d5d8ffda713.webp",981,1248,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ecb6e27b71e85339fa7c02aa9f7ce81b.webp",980,1247]